Advertisement
U.S. markets open in 3 hours 44 minutes

LakeShore Biopharma Co., Ltd (LSBPW)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
0.04000.0000 (0.00%)
At close: 04:00PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.74
52-Week Change 3N/A
S&P500 52-Week Change 331.18%
52 Week High 30.0400
52 Week Low 30.0400
50-Day Moving Average 3N/A
200-Day Moving Average 3N/A

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 5N/A
Implied Shares Outstanding 6N/A
Float 83.6M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends N/A
Most Recent Quarter (mrq)N/A

Profitability

Profit Margin -75.59%
Operating Margin (ttm)-68.83%

Management Effectiveness

Return on Assets (ttm)-13.85%
Return on Equity (ttm)-65.99%

Income Statement

Revenue (ttm)573.42M
Revenue Per Share (ttm)53.63
Quarterly Revenue Growth (yoy)27.70%
Gross Profit (ttm)N/A
EBITDA -315.9M
Net Income Avi to Common (ttm)-433.46M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)246.35M
Total Cash Per Share (mrq)12.91
Total Debt (mrq)424.46M
Total Debt/Equity (mrq)72.53%
Current Ratio (mrq)1.13
Book Value Per Share (mrq)30.76

Cash Flow Statement

Operating Cash Flow (ttm)-295.23M
Levered Free Cash Flow (ttm)-216.49M